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cAMP-dependent protein kinase A and the dynamics of epithelial
cell surface domains: moving membranes to keep in shape
Abstract
Cyclic adenosine monophosphate (cAMP) and cAMP-dependent protein kinase A (PKA) are
evolutionary conserved molecules with a well-established position in the complex network of signal
transduction pathways. cAMP/PKA-mediated signaling pathways are implicated in many biological
processes that cooperate in organ development including the motility, survival, proliferation and
differentiation of epithelial cells. Cell surface polarity, here defined as the anisotropic organisation of
cellular membranes, is a critical parameter for most of these processes. Changes in the activity of
cAMP/PKA elicit a variety of effects on intracellular membrane dynamics, including membrane sorting
and trafficking. One of the most intriguing aspects of cAMP/PKA signaling is its evolutionary
conserved abundance on the one hand and its precise spatial-temporal actions on the other. Here, we
review recent developments with regard to the role of cAMP/PKA in the regulation of intracellular
membrane trafficking in relation to the dynamics of epithelial surface domains.
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Abstract 
Cyclic adenosine monophosphate (cAMP) and cAMP-dependent protein kinase A 
(PKA) are evolutionary conserved molecules with a well-established position in the 
complex network of signal transduction pathways. cAMP/PKA-mediated signaling 
pathways are implicated in many biological processes that cooperate in organ 
development including the motility, survival, proliferation, and differentiation of 
epithelial cells. Cell surface polarity, here defined as the anisotropic organisation of 
cellular membranes, is a critical parameter for most of these processes. Changes in the 
activity of cAMP/PKA elicit a variety of effects on intracellular membrane dynamics, 
including membrane sorting and trafficking. One of the most intriguing aspects of 
cAMP/PKA signaling is its evolutionary conserved abundance on the one hand and its 
precise spatial-temporal actions on the other. Here, we review recent developments 
with regard to the role of cAMP/PKA in the regulation of intracellular membrane 
trafficking in relation to the dynamics of epithelial surface domains.  
 
 2
An introduction to epithelial cell surface polarity and cAMP-dependent protein 
kinase A  
The ability of cells to establish a polarized phenotype, which includes an anisotropic 
organisation and asymmetry of their plasma membranes, is fundamental for organism 
development and functioning. While this includes many cell types including 
(migrating) fibroblasts, one of the best studied cases of cell surface asymmetry is that 
exhibited by the epithelium, one of the four primary body tissues. Epithelial cells line 
most body cavities and display structurally and functionally distinct cell surface 
domains (1). These include apical and basolateral surface domains which face the body 
exterior and underlying tissue, respectively (figure 1A). Apical and basolateral cell 
surface domains differ in protein and lipid composition, a feature that is vital for these 
cells to perform domain-specific functions such as the selective uptake and excretion 
of molecules and protection of the body against pathogens and toxic compounds. Cell 
surface polarity is generated and maintained in spite of continuous exo-, endo-, and 
transcytotic membrane fluxes between these domains and intracellular organelles 
(figure 1A). The intracellular sorting of newly synthesized and recycling proteins and 
lipids is therefore crucial to generate and maintain such specific plasma membrane 
compositions, as well as to tailor these to meet changing physiological needs (2,3). 
Predominant sorting stations for basolateral and apical plasma membrane components 
in epithelial cells are provided by the Golgi apparatus and/or the recently identified 
subapical compartment/ common recycling endosome (4-6) (Figure 1A).   
 Cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) have 
emerged as key signaling molecules that regulate the intracellular sorting and 
trafficking of basolateral and apical membrane components and, consequently, are 
involved in the functional dynamics of epithelial cell surface domains, in response to 
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extracellular cues. For example, in the renal collecting duct, the reabsorption of water 
is regulated by the antidiuretic hormone vasopressin which, upon binding to its 
receptor on the basolateral surface of kidney epithelial cells stimulates cAMP 
production and the PKA-mediated trafficking of water channels from the Golgi 
apparatus and/or endosomes to the apical membrane, thereby allowing water 
reabsorption from the pro-urine (7) (figure 1B). In the entero-hepatic circulation, 
peptide hormones that are secreted following a meal increase cAMP production in 
hepatocytes leading to increased PKA-mediated trafficking of ABC transporters from 
the Golgi apparatus and/or endosomes to the apical, bile canalicular domain. This 
stimulates the secretion of bile acids that, in turn, can help digest fats in the intestinal 
apical lumen (8) (figure 1B). One of the most important questions in this research field 
is how PKA activation, elicited by various extracellular stimuli, produces specific 
effects on the dynamics of distinct and spatially separated intracellular membrane 
systems. To address this question, insight in the structural and spatial-temporal 
dynamics of cAMP-PKA complexes is crucial.   
In mammalian cells, PKA is a holoenzyme (9) which consists of two regulatory 
and two catalytic subunits. Four different regulatory subunits are distinguished, RIα, 
RIβ, RIIα, and RIIβ, the expression of which is tissue-dependent and developmentally 
regulated by a protein kinase A inhibitor called PKI. Regulatory subunits of PKA bind 
to free catalytic subunits (α, β, γ, or PRkX) and their primary function appears to keep 
the catalytic subunits in an inactive state. Two molecules of cAMP, which is produced 
by any of the nine known mammalian adenylyl cyclases in response to activation of G 
proteins coupled to different membrane receptors, bind to each regulatory subunit of 
PKA and causes the subsequent release and activation of the catalytic subunits (10,11). 
These, in turn, can phosphorylate target proteins at serine and threonine residues. 
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cAMP phosphodiesterases (PDEs), which comprise eleven distinct families yielding a 
multitude of invariably expressed PDE isoforms (12), play an important part in 
regulating PKA activity by restricting local cAMP levels. In addition to the control of 
local cAMP concentrations by adenylyl cyclase and PDEs, a family of more than fifty 
A-kinase anchoring proteins (AKAPs) (13) control the spatial distribution of the 
different PKA holoenzymes and, thereby, focuss their access to substrate proteins. 
AKAPs interact with dimers of PKA regulatory subunits with a high but varying 
affinity (14) and anchor RII subunits at among others the nucleus, cytoskeleton, 
organelle membranes, and plasma membrane (15-17). While most AKAPs anchor RII 
subunits, so-called dual AKAPS have recently been identified which also anchor RI 
subunits. These include D-AKAPs at the endoplasmic reticulum and mitochondria (18), 
and BIG1 and BIG2 at the Golgi apparatus and recycling endosomes (19). Most 
AKAPs also contain regions for binding additional enzymes, e.g. PDEs, adenlyl 
cyclase, protein phosphatases, and other kinases (20-21). As unique signaling platforms 
AKAPs thus can create regulatory networks that ensure the coordinated propagation 
of PKA signals through different locations in the cell. Such a coordinated signal 
propagation may be of particular importance in directing the sequential steps involved 
in the sorting and vesicular trafficking of proteins and lipids through the cells, often 
bridging many micrometers. Indeed, AKAPs and PKA isoforms are found at many 
organelles that mediate the intracellular sorting and trafficking of membrane proteins 
and lipids, e.g. the microtubule-organizing center (MTOC) or centrosome (22), 
cytoskeleton (23), the plasma membrane (24), Golgi apparatus (19,25) and endoplasmic 
reticulum (18) (figure 2A), sometimes complexed with cargo proteins (see below). In 
the following sections, we will review the literature with regard to the role of 
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cAMP/PKA signaling in intracellular membrane trafficking and the dynamics of cell 
surface domains. 
 6
The role of cAMP/PKA in exocytosis 
The polarization of exocytosis is a fundamental mechanism for the targeted secretion 
of molecules and to localize plasma membrane components to specific regions of the 
cell surface in order to establish, maintain, and/or tailor functional cell surface 
domains. Elevation of the intracellular cAMP concentration enhances exocytic 
transport of proteins to the apical surface in among others pancreatic β-cells (26), 
kidney (27,28), intestine (29,30), hepatic (31,32), and principal (33-35) epithelial cells. A 
similar process is observed in neurons, where a rise in intracellular cAMP 
concentration enhances exocytic transport to and neurotransmitter release at the 
axonal synapse (36,37), the latter being considered the equivalent of the epithelial apical 
surface domain. Most of the effects of cAMP are mediated by PKA, although some 
are mediated by other cAMP effectors such as Epac, a guanine nucleotide exchange 
factor for the small GTPase Rap1, or calcium channels (38). While the cAMP/PKA 
system in mammalian cells is highly redundant with multiple genes encoding several 
PKA regulatory and catalytic subunits (see paragraph above), Drosophila have a 
single or predominant gene encoding the PKA catalytic subunit, DC0, which is 
preferentially expressed in mushroom bodies in the brain (39). Drosophila DC0 
mutants which lack PKA catalytic activity show defects in neurotransmitter release in 
response to extracellular cues including cAMP (40,41), and display learning and 
memory deficits (39,42,43), underscoring the involvement of PKA in the dynamics of the 
axonal surface and synaptic plasticity. Excellent review articles have recently 
addressed the role of cAMP/PKA in regulating exocytosis in neurons in relation to 
synaptic plasticity, learning, and memory (44,45). Here we will focus on epithelial cells.  
Studies with cultured primary cells and epithelial cell lines have demonstrated 
that stimulation of apical surface-directed trafficking in response to an elevated 
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intracellular cAMP concentration can be linked to signaling molecules that circulate 
outside epithelial cells. For instance, the peptide hormone secretin stimulates apical 
exocytosis of membrane vesicles in bile duct epithelial cells through elevation of 
cAMP levels and subsequent activation of PKA (46). A similar phenomenon is 
observed in hepatocytes stimulated by glucagon which activates adenylyl cyclase 
activity and cAMP production (47). In accordance with those observations, H89, an 
inhibitor that also inhibits the activity of the catalytic subunit of PKA, perturbs 
intracellular trafficking of apical secretory proteins, as shown for instance in lacrimal 
cells (48). It has been proposed that cAMP modulates the rate of 'constitutive' 
exocytosis (31), showing little specificity for the different apical membrane 
components. This may suggest that cAMP/PKA targets molecular machineries that 
control vesicular membrane flow in general. However, as will be discussed in the next 
paragraph, there are also examples in which PKA controls the intracellular flow of 
specific ‘cargo’ proteins and lipids. 
The involvement of cAMP/PKA signaling in the apical exocytosis of specific 
proteins has mostly focused on polytopic membrane transporter proteins. These 
include aquaporins, a class of integral membrane proteins that form water channels in 
the plasma membrane to selectively conduct water molecules, and important for the 
functioning of all fluid-transporting epithelia. In Madin-Darby canine kidney 
(MDCK) epithelial cells, PKA activity is required for the apical trafficking of 
vasopressin-controlled aquaporin (AQP)2 (49). AQP2 possesses a single consensus 
cAMP-dependent PKA phosphorylation site at Ser256. PKA phosphorylation 
modulates its distribution between plasma membrane and intracellular vesicular 
compartments (50,51). The role of PKA-mediated phosphorylation of AQP2 at Ser256 is 
somewhat obscured by the notion that AQP2 transition in the Golgi apparatus is 
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associated with a PKA-independent increase in AQP2 phosphorylation at Ser256, 
probably mediated by Golgi-associated casein kinase 2 (52). In renal collecting duct 
principal cells, cAMP/PKA-induced AQP2 translocation is sensitive to Ht31, a 
peptide that binds with high affinity to PKA type II regulatory subunits and in this 
way displaces the PKA-RII holoenzyme from its subcellular anchoring sites (37). A 
similar sensitivity of exocytosis to HT31 was earlier demonstrated for the cAMP-
responsive insulin secretion in clonal beta cells in response to the insulinotropic 
hormone glucagon-like peptide 1 (53). Localized activity of PKA type II at AQP2-
bearing vesicles thus appears responsible for the efficient trafficking of AQP2 to 
apical surface (37). Interestingly, PKA-RIIα is part of a multi-protein signalling 
complex located at endosomal membranes in inner medullary collecting duct (IMCD) 
cells (54). In this study, AQP2 is shown to be a substrate for protein phosphatase 2B 
which, in conjunction with PKA, is responsible for the phosphorylation status that 
controls AQP2 trafficking and steady state distribution. In addition, PDE4D interacts 
with PKA-RII on AQP2-bearing vesicles, and is activated in a PKA-dependent 
manner upon translocation of these vesicles to the apical cell surface to reduce 
osmotic water permeability (55). The responsible AKAP that mediates PKA-RII-
regulated AQP2 translocation in renal collecting duct principal cells is AKAP18delta 
(56,57). Although the consensus PKA phosphorylation site at Ser256 in AQP2 is clearly 
important for the subcellular distribution of AQP2, the mechanism by which 
phosphorylation of AQP2 by PKA controls its intracellular trafficking remains 
unclear. For instance, it remains to be verified that PKA type II, anchored to 
AKAP18delta in endosomal membranes, is responsible for the phosphorylation of 
AQP2 at Ser256. It can be speculated that phosphorylation of AQP2 masks or 
unmasks a signal that is recognized by molecular machineries that prevent or promote 
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apical surface delivery, respectively, similar as proposed for the adhesion protein 
NgCAM (58). 
In addition to controlling the apical exocytosis of aquaporins, PKA-RIIα 
anchoring controls the efficient trafficking of the polytopic multidrug resistance 
protein MDR-1 (or ABCB1) from the Golgi apparatus to the apical bile canaliuclar 
surface of hepatocytes, the prime epithelial cells of the liver (59). At the apical surface 
of hepatocytes, MDR-1 is necessary for the formation of bile and to reduce the body 
load of potentially harmful compounds (60). Wojtal et al. (59) displaced PKA-RIIα from 
Golgi-associated AKAPs in human hepatocytes using the small interfering AKAP-IS 
peptide designed by Scott and colleagues (61). Displacement of PKA-RIIα causes a 
delay of MDR-1 trafficking to the apical surface of hepatic HepG2 cells. This effect is 
specific for MDR-1 as other apical resident proteins such as the multidrug resistance 
protein MRP2, dipeptidyl peptidase IV and 5’-nucleotidase are unaffected. This 
suggests that PKA-RIIα anchoring is not required for membrane traffic to the apical 
domain per se. In addition to the delay in trafficking of MDR1, which in contrast to 
AQP2 lacks a consensus PKA phosphorylation site, the displacement of PKA-RIIα 
from Golgi-associated AKAPs inhibits the Golgi to apical surface-directed transport 
of newly synthesized glycosphingolipid analogues and instead reroutes these to the 
basolateral surface. This suggests that the trafficking of MDR-1 and 
glycosphingolipids are mechanistically linked in a manner that depends on PKA-RIIα 
anchoring at the Golgi. This is supported by the observation that treatment of HepG2 
cells with an inhibitor of glucosylceramide synthesis results in a delayed translocation 
of MDR-1, but not MRP2, to the apical surface, very similar as observed upon 
displacement of PKA-RIIα (59). Because of the known interrelation between 
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glycosphingolipids and MDR1 (62), it is proposed that the mistargeting of 
glycosphingolipids may be responsible for the delay in MDR1 exocytosis (59). 
As a final example, activation of PKA enhances the apical surface-directed 
transport of the cystic fibrosis transmembrane conductance regulator (CFTR) (63-64). 
CFTR activity functionally correlates to the interaction of PKA-RII with unspecified 
but Ht31 peptide-sensitive AKAPs (65). Also, the direct phosphorylation of CFTR by 
PKA affects its intracellular trafficking (66,67) and cAMP increases CFTR expression 
(67). Taken together, the evidence indicates that PKA-RII anchoring and activity at 
endosomes and organelles of the secretory pathway control the proper trafficking and, 
consequently, the steady state distribution of select polytopic apical plasma membrane 
transporter proteins. 
In addition to regulating the trafficking of specific ‘cargo’ proteins and lipids 
as described in the paragraph above, PKA targets molecular machineries that control 
vesicular membrane flow in general. For instance, PKA activity influences the rate of 
membrane vesiculation at the Golgi apparatus by stimulating the scission of 
membrane transport vesicles (68) (figure 2B). It has been proposed that PKA-RIIα 
controls this process and that the interaction of PKA-RIIα subunits with Golgi 
cisternae is modulated by trimeric G proteins (69). Increased PKA activity (isoform not 
specified) triggers the redistribution of the ADP-ribosylating factor Arf1 from cytosol 
to trans-Golgi membranes in a cell-free assay, and this is abolished with PKA 
inhibitory peptides or when cytosol is depleted of PKA catalytic subunits (70). Two 
Golgi-associated Arf-activating proteins, the Brefeldin A-inhibited guanine 
nucleotide-exchange proteins (GEPs) BIG1 and BIG2, are both AKAPs (19). Elevation 
of cAMP caused PKA-catalyzed phosphorylation of the BIGs and, in an in vitro 
assay, recombinant PKA altered their GEP activity (71). The involvement of PKA in 
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Golgi membrane dynamics was recently supported by the notion that the cell-wide 
downregulation of PKA-RIIα subunits by siRNA results in severe perturbation of 
Golgi morphology (72). Protein phosphorylation mediated by PKA affects Golgi 
morphology in yeast via phosphorylation of the t-SNARE (soluble N-ethylmaleimide-
sensitive fusion protein attachment protein receptors) protein Sed-5, which controls 
membrane fusion (73). Also in mammalian cells, several potential targets of PKA 
involved in vesicular trafficking act in membrane fusion. In polarized neurons for 
example, these include syntaphilin, a protein interacting with dynamin-1 and 
syntaxin-1 which, in turn, regulate the scission and fusion of secretory vesicles, 
respectively, at the axonal synapse (the neuronal equivalent of the epithelial apical 
plasma membrane domain (74)). The phosphorylation of syntaphilin by PKA on Ser43 
in isolated rat brain synaptosomes or syntaphilin-transfected HEK293 cells inhibits its 
interaction with dynamin- and syntaxin-1 (75), and annuls its inhibitory effect on 
synaptic vesicle exocytosis (figure 2B). In cultured superior cervical ganglion 
neurons, PKA phosphorylates tomosyn which, like synthaphilin, is a member of 
SNARE regulatory protein family that limits synaptic transmission. Thus, PKA-
mediated phosphorylation of tomosyn reduces its inhibitory interaction with syntaxin-
1 and promotes SNARE assembly, exocytic vesicle fusion, and the release of 
neurotransmitters in response to a potent biological mediator, the pituitary adenylate 
cyclase-activating polypeptide (26). Other molecular targets of PKA implicated in 
exocytosis include cystein string protein, rabphilin 3A, αSNAP (N-ethylmaleimide 
sensitive factor attachment protein), snapin, SNAP-25 and syntaxin 4 (38,76). The PKA-
mediated phosphorylation of these proteins changes their respective protein-protein 
interactions and, in this way, modulates the vesicle priming and/or fusion stages of 
exocytosis. PKA may thus control exocytosis at different steps of the pathway, e.g. 
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vesicle budding and scission from the donor membrane such as the Golgi apparatus or 
endosomes, and vesicle fusion with the target (plasma) membrane. 
The cytoskeleton network, including actin filaments and microtubules, are 
instrumental in directing transport vesicles to defined subcellular sites (77). 
Cytoskeleton-associated AKAPs have been reported (23). PKA regulatory subunits 
form complexes with dynein, and with kinesin II and myosin V, and in this way 
control the spatial organisation of pigment granules in melanophores (78). Also the 
epinephrine-induced clustering of secretory Weibel-Pallade bodies in endothelial cells 
involves a PKA-dependent regulation of the dynein-dynactin complex (79), and 
inhibition of PKA-RII anchoring in human hepatoma cells results in a (non-polar) 
repositioning of the centrosome and surrounding recycling endosomes (80). In the latter 
study, surprisingly, inhibition of catalytic PKA activity did not alter the position of 
the centrosome and recycling endosomes. It thus appears that regulatory PKA 
subunits, through their interaction with cytoskeleton motor proteins, can control the 
spatial distribution of secretory organelles. Whether and how this may influence the 
movement of transport vesicles remains to be investigated.    
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The role of cAMP/PKA in endocytosis 
Besides stimulating exocytosis, activation of the cAMP-dependent second messenger 
pathway causes a significant reduction in endocytosis in epithelial T84 cells as 
measured by uptake of fluid-phase markers (81). Furthermore, cAMP stimulates the 
exocytosis of CFTR but at the same time inhibits its apical endocytosis (82,83). In case 
of AQP2, PKA-mediated phosphorylation of Ser256 not only stimulates exocytosis of 
the water channel, but is also required for its subsequent reinternalization (84). This 
and other data underscore that the process of exocytosis is closely correlated to the 
endocytosis of membrane components, which provides an efficient way of controlling 
the size and composition of plasma membrane domains and, therefore, functional cell 
surface polarity. Perhaps therefore not surprisingly, there are numerous reports 
implicating PKA as a regulator of the endocytic process. In some instances, PKA 
directly phosphorylates the ‘cargo’ protein. Indeed, the low density lipoprotein-related 
protein LRP is phosphorylated by PKA at Ser76, and mutations of Ser76 result in a 
decrease in the initial endocytosis rate of LRP and a lower efficiency in delivery of 
ligand for degradation (85). While PKA activity may promote the endocytosis of LRP, 
the agonist-stimulated endocytosis of glutamate receptors is inhibited by PKA 
activation, which may reduce the interaction of glutamate receptors with G-coupled 
receptor kinase 2 and arrestins (87). Interestingly, inhibition of basal PKA activity 
induces clathrin-mediated endocytosis of unoccupied, inactive epidermal growth 
factor receptors (EGFR) and its accumulation into early endosomes without affecting 
the endocytosis of transferrin and µ-opioid receptors. It is proposed that the 
predominant distribution of inactive EGFR at the plasma membrane involves a PKA-
dependent restrictive condition resulting in receptor avoidance of endocytosis until it 
is bound and activated by a ligand (86). PKA may control endocytosis by associating 
 14
with compositionally and biophysically distinct plasma membrane domains. For 
instance, the PKA catalytic subunit interacts with caveolin-1, a key component of 
caveolar membranes domains (88), and PKA-mediated phosphorylation triggers the 
agonist-induced internalization of G-protein coupled beta1-adrenergic receptors via a 
caveolar pathway in non-polarized cells (89). PKA also controls protein recycling to 
the plasma membrane following endocytosis. For instance, AKAP79, which interacts 
with a PDZ domain in the beta1-adrenergic receptor, mediates the targeting of PKA-
RII to these receptors, and their subsequent PKA-mediated phosphorylation promotes 
recycling of the receptors from endosomal membranes back to the plasma membrane 
and, in this way, the functional resensitization of the receptor (90). Whether AKAPs, 
PKA, and receptors traffic as a complex and whether they can, in this way, direct their 
transit through the heterogeneous endosomal membrane system (as suggested by 
Stefan et al., (55)) remains to be investigated. In addition to the role of PKA in setting 
the trafficking itinerary of beta1-adrenergic receptors, AQP-4 in human gastric cells is 
phosphorylated by PKA subsequent to its endocytosis from the basolateral surface, 
and it is suggested that this phosphorylation is involved in retaining AQP4 in an 
endosomal recycling compartment (91). Downstream in the endocytic pathway, PKA-
RIIα regulates membrane traffic between endosomes and the Golgi apparatus and 
plays a pivotal role in endosome-to-Golgi transport of the plant toxin ricin upon 
stimulation with cAMP analogues (92). A similar stimulating effect is observed in case 
of retrograde transport of these proteins from the Golgi apparatus to the endoplasmic 
reticulum, where the toxin is eventually translocated to the cytosol where it blocks 
protein synthesis. In concert, overexpression of PKA-RIIα sensitizes cells to ricin. 
Intriguingly, non-hydrolyzable cAMP analogues stimulate non-clathrin-mediated 
endocytosis of ricin from the apical but not basolateral surface to the Golgi apparatus 
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in MDCK cells (93), suggesting that PKA-RIIα discriminates between different, i.e. 
apical versus basolateral populations of endosomes, and/or affects different endocytic 
pathways in different cell types. 
Also PKA-RI localizes to endosomes. The RIα subunit of PKA was found to 
localize on Rab7-positive late endosomes and on microtubule-associated protein light 
chain 3-positive autophagosomes in cultured cells. RIα was also shown to physically 
interact with the mTOR (mammalian target of rapamycin) kinase and affect its 
phosphorylation and activity (94). While the regulation of autophagocytosis by cAMP 
levels is highly conditional (95), in RIα downregulated mouse embryonic fibroblasts 
the number of autophagosomes is significantly reduced compared with wild-type 
cells. This suggests that PKA type I in a complex with mTOR modulates the rate of 
autophagocytosis and, possibly, the various autophagocytosis-related developmental 
processes and diseases including cancer and neurodegeneration. Taken all together, 
PKA activity is involved in the endocytosis and endocytic recycling of several 
proteins from both basolateral and apical surfaces in different cell types, and distinct 
PKA holo-enzymes may participate in the different endocytic routes. 
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The role of cAMP/PKA in transcytosis 
In epithelial cells, endocytic and exocytic membrane trafficking pathways converge to 
allow the transcellular trafficking (transcytosis) of proteins and lipids between 
basolateral and apical surfaces. Transcytosis is used by epithelia to move molecules 
across the cells in response to extracellular factors. It has been reported that Gαs 
stimulates transcytosis and apical secretion in MDCK cells through cAMP and PKA 
(29). PKA is implicated in cholesterol and caveolae-controlled transcytosis of 
basolaterally localized high-density lipoprotein scavenger receptor class B type I (SR-
BI), in MDCK cells (30). In this study, a scenario is proposed in which cholesterol-
based membrane microdomains, or rafts, promote internalization and basolateral 
recycling of internalized SR-BI whereas a PKA pool sensitive to cholesterol depletion 
mediates SR-BI transcytosis (30). The exact intracellular location at which PKA 
promotes SR-BI transcytosis is not clear. However, a switch from basolateral 
recycling to apical transcytosis of membrane components typically occurs in the 
endosomal system. This has been clearly demonstrated in polarized hepatocytes. In 
these cells, cAMP/PKA activates an apical surface-directed pathway exiting from a 
subapical compartment/ common recycling endosome (SAC/CE), and changes the 
trafficking of the fluorescently labelled sphingolipid analogues C6-NBD-
sphingomyelin and -galactosylceramide from a apical-to-SAC/CE-to-basolateral 
itinerary to a apical-to-SAC/CE-to-apical pathway (96,97). The activated SAC/CE-to-
apical pathway represents the final leg in the basolateral to apical transcytotic route 
(90). Indeed, the SAC/CE connects basolateral and apical endocytic routes and thus 
takes a prominent position in the transcytotic pathway (5,98,99). The PKA inhibitor H89 
prevents the cAMP/PKA-induced apical flow of the fluorescent lipids from the 
SAC/CE as well as that of transcytosing proteins (100). By contrast, the constitutive 
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apical recycling of C6-NBD-glucosylceramide from the SAC/CE is unaffected by 
PKA inhibition (100). Importantly, the stimulatory effect of cAMP/PKA on the apical-
directed flow of the sphingomyelin analogues from the SAC/CE strongly coincides 
with enhanced development of apical plasma membrane domains, suggesting that 
PKA-stimulated trafficking from the SAC/CE (i.e. the last step of the transcytotic 
pathway) and the biogenesis of apical plasma membrane domains are intimately 
linked. 
The downstream targets of cAMP/PKA that regulate trafficking between the 
SAC/CE and the apical surface are not yet known. Elevated cAMP promotes the 
turnover of the sphingoid base dihydro-sphingosine (sphinganine) to dihydroceramide 
by stimulating the activity of dihydroceramide synthase (101), and reduced and elevated 
levels of sphinganine promote and inhibit apical surface development, respectively. 
As a part of the underlying mechanism, dihydroceramide synthase activity and 
ensuing low sphinganine levels are required for cAMP/PKA-mediated activation of 
the apical-surface-directed trafficking pathway from the SAC/CE (101). Interestingly, a 
sphingosine kinase-interacting protein, SKIP, which mediates the phosphorylation of 
sphingoid bases, anchors PKA (102); supporting the notion that sphingoid base 
metabolism may be regulated by PKA. 
The correlation between PKA-stimulated trafficking from the SAC/CE and the 
biogenesis of apical plasma membrane domains is further corroborated by the 
observation that the interleukin 6 family cytokine oncostatin M (OSM), an important 
factor in fetal liver development, stimulates apical plasma membrane biogenesis in 
hepatocytes in a PKA-dependent manner (103). Stimulation of hepatocytes with OSM 
does not elevate cAMP levels or stimulate overall PKA activity but enhances the 
association of PKA-RIIα with centrosomes in an ERK1-dependent manner (80,103). 
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Displacement of PKA-RIIα from the centrosome, by means of a small interfering 
peptide (80) or by forcing synchronised hepatocytes into the S-phase of the cell cycle 
(104), prevents the stimulatory effect of OSM on apical membrane biogenesis. Given 
that OSM stimulates PKA-dependent membrane transport exiting from the SAC/CE 
to promote apical membrane biogenesis (103), the recruitment of PKA-RIIα at the 
centrosome may be an important factor in the regulation of polarized, apical surface-
directed membrane trafficking from the SAC/CE in response to extracellular 
cytokines. However, this remains to be investigated.  
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Conclusions and perspectives 
PKA holoenzymes play an important role in the polarized trafficking of membrane 
proteins and lipids, including exocytosis, endocytosis, and transcytosis. In this way, 
cAMP/PKA signalling contributes to the compositional and functional dynamics of 
epithelial cell surface domains and, accordingly, developmental processes and organ 
function. The dynamics of membrane protein trafficking can be regulated by PKA-
mediated phosphorylation of the cargo protein itself, such as in case of the aquaporins 
and other transporter proteins, or regulated by PKA-mediated phosphorylation of 
components of the molecular machineries that more generally control vesicular 
membrane trafficking. Furthermore, PKA can interfere with the morphology and, 
consequently, the functioning of organelles that control membrane trafficking, such as 
the Golgi apparatus or endosomes. One of the most intriguing developments may be 
the interaction of selected cargo with PKA scaffolds to create a multi-signal 
transduction module that controls its trafficking itinerary through the different 
organelles.     
 The specificity of cAMP/PKA signalling in the regulation of membrane 
trafficking in any given cell is dictated at multiple and interconnected levels. These 
include: i) the nature of the extracellular (ant)agonist and cellular receptor, ii) spatial-
temporal cAMP gradients, carefully controlled by a large family of adenylyl cyclases 
and PDEs, iii) the composition and spatial distribution of the PKA holoenzyme, 
mediated by different regulatory and catalytic subunits and a large family of AKAPs, 
and iv) the nature of the catalytic subunit’s substrate, which can be cargo itself or 
traffic regulatory proteins.  
Because the increase of exocytosis by cAMP/PKA signalling is observed in a 
wide variety of secretory cell types, this is likely an important and fundamental 
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mechanism. However, although this phenomenon has been recognized for more than a 
decade, it remains largely unexplained at the molecular level. This is primarily due to 
the increasingly apparent complexity of cAMP/PKA signaling. For instance, to date 
there are at least five AKAPs reported just in the secretory pathway. Each of these 
AKAPs anchor RI or RII subunits or, in case of D-AKAP-1 and BIG1/2, both, 
sometimes via distinct and/or multiple binding sites. These AKAPs in addition can 
bind PDEs, adenylyl cyclases, and other signalling molecules, thereby tuning and 
propagating local cAMP/PKA responses. It is for that reason that the use of non-
hydrolyzable cAMP analogues in combination with inhibitors of general PKA 
catalytic activity may be useful to reveal the general involvement of PKA activity in 
the exocytic process but, importantly, does not provide the necessary information with 
regard to the PKA isoenzymes involved and their precise subcellular location. This 
limitation also hampers the identification and analysis of relevant phosphorylation 
targets. The current development of novel and innovative tools, such as PKA 
holoenzyme-specific cAMP analogues (105), In vivo assays that measure the 
interaction of specific regulatory and catalytic subunits as a mesasure for PKA 
holoenzyme-specific activity (105), and peptide-based disruptors of specific PKA-
AKAP interactions (61; 106-109), used in combination with established biochemical and 
(live) cell biological assays, is expected to boost our understanding of the role of PKA 
signaling in membrane dynamics and the plasticity of cell surface domains, and the 
life-facilitating processes that are so critically dependent thereof. 
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Legends 
 
Figure 1. Organization of and trafficking pathways in epithelial cells. A. 
Illustration of trafficking pathways serving the apical (blue) and basolateral 
(green) surface domains in polarized epithelial cells. Red, blue and black arrows 
and circles indicate exocytic, endocytic, and transcytotic transport routes, 
respectively. RE: recycling endosomes. B. examples of stimulated apical 
exocytosis in renal collecting duct cells and hepatocytes in response to a 
cAMP/PKA-stimulating agonist/ligand.  
 
Figure 2. The involvement of PKA-AKAP in vesicular transport. A. PKA and 
AKAPs localize to the different organelles that make up the exocytotic pathaway 
including the endoplasmic reticulum, the Golgi apparatus, endosomes, and the 
plasma membrane. Thick grey lines represent cytoskeleton fibers. B. Possible 
molecular roles of PKA in the budding and scission of transport vesicles from a 
donor organelle, in this case the Golgi apparatus, and in the fusion of transport 
vesicles with the acceptor membrane, in this case the plamsa membrane. Note that 
the distinct contributions of each PKA isoenzyme (I and II) in the regulation of 
vesicular transport pathways by D-AKAP1 or BIG2 has not been experimentally 
addressed. 
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